Suppr超能文献

在一系列首次经内镜诊断为结直肠癌的连续患者中遗传性非息肉病性结直肠癌的患病率:一项多中心研究。意大利协作组

Prevalence of HNPCC in a series of consecutive patients on the first endoscopic diagnosis of colorectal cancer: a multicenter study. The Italian Collaborative Group.

作者信息

Riegler G, Savastano A, Selvaggi F, Ciociano R, Martino R, Riccio G, Iorio R, Ponti G, Carratú R, Borgheresi P, de Filippo G, Rossi G B, Tempesta A M, de Palma G D, Catanzano C, Russo P, Bianco M A, Piscitelli A, di Carlo V, Baldi V, Avagliano P, Guardascione F, Petrelli G, di Giorgio P, Beatrice M

机构信息

Dept. of Clinical and Experimental Internal Medicine, Second University of Naples, Italy.

出版信息

Endoscopy. 1999 Jun;31(5):337-41. doi: 10.1055/s-1999-30.

Abstract

BACKGROUND AND STUDY AIMS

It is difficult to measure the prevalence of hereditary non-polyposis colorectal cancer (HNPCC) in geographical areas that do not have tumor registers, as is the case in the present study, and it was therefore decided to assess the prevalence in Italy using different methods.

PATIENTS AND METHODS

The pedigree was established for 485 of 501 colorectal cancer patients diagnosed with colorectal carcinomas. Patients were included consecutively in 13 gastroenterology centers; they had not taken part in prevention examinations. Information was collected regarding the neoplastic pathology observed in the families, confirmed in 90% of cases among 3515 first-degree relatives and in 79.5% of cases among 7068 second-degree relatives.

RESULTS

In the 3515 first-degree relatives (1002 parents, 1560 siblings and 953 children), 61 colorectal carcinomas, 29 carcinomas in the digestive tract outside the colon, and 99 carcinomas in other locations were reported. Only five of the 485 patients (1%) satisfied the Amsterdam criteria (three cancers, two of which were in first-degree relatives in different generations and one in a relative younger than 50). When broadening the criteria that we are proposing (satisfying only two of the three Amsterdam criteria), the prevalence would increase to 3% (15 cases).

CONCLUSIONS

Modifying the criteria makes it easier to identify new mutations or confirm the existence of those already known, as well as allowing preventative treatment in relatives who are apparently healthy.

摘要

背景与研究目的

在没有肿瘤登记系统的地区,如本研究所在地区,很难测量遗传性非息肉病性结直肠癌(HNPCC)的患病率,因此决定采用不同方法评估意大利的患病率。

患者与方法

为501例诊断为结直肠癌的患者中的485例建立了家系。患者连续纳入13个胃肠病学中心;他们未参加过预防检查。收集了有关家族中观察到的肿瘤病理学信息,在3515名一级亲属中有90%的病例得到证实,在7068名二级亲属中有79.5%的病例得到证实。

结果

在3515名一级亲属(1002名父母、1560名兄弟姐妹和953名子女)中,报告了61例结直肠癌、29例结肠外消化道癌和99例其他部位癌。485例患者中只有5例(1%)符合阿姆斯特丹标准(3例癌症,其中2例在不同代的一级亲属中,1例在50岁以下的亲属中)。当放宽我们提出的标准(仅满足阿姆斯特丹三项标准中的两项)时,患病率将增至3%(15例)。

结论

修改标准有助于识别新的突变或确认已知突变的存在,也有助于对看似健康的亲属进行预防性治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验